Holdings (as at 2026-04-07)
Percentage of net assets may not equal 100%
Security Name % of Net Assets
Humana Inc. 2.51%
Elevance Health Inc. 2.35%
Globus Medical, Inc. (Class A) 2.30%
HCA Healthcare, Inc. 2.29%
The Cigna Group 2.27%
Exelixis, Inc. 2.26%
Universal Health Services, Inc. (Class B) 2.23%
Zimmer Biomet Holdings, Inc. 2.23%
Cardinal Health, Inc. 2.22%
Incyte Corporation 2.20%
Bio-Rad Laboratories, Inc. (Class A) 2.20%
Regeneron Pharmaceuticals, Inc. 2.17%
DaVita Inc. 2.15%
Biogen Inc. 2.11%
Solventum Corporation 2.11%
Encompass Health Corporation 1.93%
Molina Healthcare, Inc. 1.87%
Tenet Healthcare Corporation 1.82%
Chemed Corporation 1.82%
Organon & Co. 1.80%
QIAGEN N.V. 1.77%
Masimo Corporation 1.77%
Penumbra, Inc. 1.77%
Insmed Incorporated 1.76%
Merck & Co., Inc. 1.75%
Becton, Dickinson and Company 1.74%
Ionis Pharmaceuticals, Inc. 1.74%
Amgen Inc. 1.71%
Pfizer Inc. 1.70%
United Therapeutics Corporation 1.68%
Sarepta Therapeutics, Inc. 1.40%
Natera, Inc. 1.39%
Illumina, Inc. 1.36%
ResMed Inc. 1.33%
Quest Diagnostics Incorporated 1.33%
Henry Schein, Inc. 1.33%
Revvity, Inc. 1.33%
Labcorp Holdings Inc. 1.33%
Medtronic Plc 1.32%
Gilead Sciences, Inc. 1.32%
Steris Plc 1.31%
Certara, Inc. 1.31%
GE HealthCare Technologies Inc. 1.30%
The Cooper Companies, Inc. 1.29%
Bristol-Myers Squibb Company 1.26%
UnitedHealth Group Incorporated 1.00%
Medpace Holdings, Inc. 0.94%
Waters Corporation 0.91%
Eli Lilly and Company 0.89%
Abbott Laboratories 0.88%
Thermo Fisher Scientific Inc. 0.88%
Neurocrine Biosciences, Inc. 0.88%
Agilent Technologies, Inc. 0.88%
BioMarin Pharmaceutical Inc. 0.88%
IQVIA Holdings Inc. 0.88%
Halozyme Therapeutics, Inc. 0.87%
Zoetis Inc. 0.87%
Johnson & Johnson 0.86%
Align Technology, Inc. 0.86%
Medline Inc. (Class A) 0.86%
West Pharmaceutical Services, Inc. 0.43%
Viking Therapeutics, Inc. 0.43%
Danaher Corporation 0.42%
Stryker Corporation 0.42%
IDEXX Laboratories, Inc. 0.42%
Edwards Lifesciences Corporation 0.42%
DexCom, Inc. 0.42%
Sotera Health Company 0.42%
Boston Scientific Corporation 0.41%
Intuitive Surgical, Inc. 0.41%
Veeva Systems Inc. (Class A) 0.41%
Envista Holdings Corporation 0.41%
Vertex Pharmaceuticals Incorporated 0.40%
Alnylam Pharmaceuticals, Inc. 0.40%
Royalty Pharma Plc (Class A) 0.40%
AbbVie Inc. 0.39%

Holdings are subject to change.

Commissions, management fees and expenses all may be associated with Exchange-Traded Fund investments. Please carefully read the prospectus of the fund before investing. Exchange-Traded funds are not guaranteed, their values change frequently and past performance may not be repeated.